See also this year's filing and all EDGAR filings for this company.
PDF Report 0001722964_2022_Y_mAbs_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001722964, Y mAbs Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 202,261,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,663,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,847,000 |
| 3 | remainder_Assets | 7,012,000 |
| 4 | LiabilitiesCurrent | 27,875,000 |
| 5 | LiabilitiesNoncurrent | 2,702,000 |
| 6 | remainder_Liabilities | 2,100,000 |
| 7 | CostOfGoodsAndServicesSold | 2,304,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 75,743,644 |
| 9 | ResearchAndDevelopmentExpense | 92,537,259 |
| 10 | remainder_Expenses | 1,730,272 |
| 11 | remainder_Revenues | 60,742,131 |
| 12 | remainder_NetIncome | 1,088,358 |
| 13 | remainder_ComprehensiveNetIncome | -573,893 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 212,783,000 |
| 1 | Liabilities | 32,677,000 |
| 2 | Expenses | 172,315,175 |
| 3 | Revenues | 60,742,131 |
| 4 | StockholdersEquity | 180,106,000 |
| 5 | NetIncome | -110,484,686 |
| 6 | ComprehensiveNetIncome | -110,771,632 |
| 7 | BaseVar | 240,089,778 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.30 |
| 9 | EconomicCapitalRatio | 3.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
